ESR1 and metastatic malignant neoplasm in the lymph nodes: ER negativity, PR negativity, tumor size >2 cm, lymph node metastasis, and high nuclear YAP1 expression were significant factors in the multivariate analysis of DFS (Supplementary Table 3).